| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 18 |
| 1 | CARBOPLATIN | 9 |
| 2 | PACLITAXEL | 8 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 8 |
| 4 | CISPLATIN | 5 |
| 5 | CETUXIMAB | 4 |
| 6 | DEXAMETHASONE | 4 |
| 7 | DEXAMETHASONE 1.5 MG | 4 |
| 8 | PEMETREXED DISODIUM | 4 |
| 9 | ESOMEPRAZOLE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM THIOSULFATE | 2 | 0.0036 |
| 1 | TEMSIROLIMUS | 3 | 0.0007 |
| 2 | CALCIUM FOLINATE | 2 | 0.0004 |
| 3 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| 4 | RAMUCIRUMAB | 1 | 0.0002 |
| 5 | MICAFUNGIN SODIUM | 1 | 0.0002 |
| 6 | BEVACIZUMAB | 18 | 0.0001 |
| 7 | CETUXIMAB | 4 | 0.0001 |
| 8 | METHYLPREDNISOLONE ACETATE | 1 | 0.0001 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 18 | 0.0001 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 4 | 0.0001 |
| 6 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 9 | 0.0001 |
| 9 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |